Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

BACKGROUND/AIMS: The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718). This post-hoc exploratory analysis sought to establish the efficacy and safety of vedolizumab in a subgroup of patients from Asia...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intest Res
Autors principals: Ooi, Choon Jin, Hilmi, Ida Normiha, Kim, Hyo-Jong, Jalihal, Umesh, Wu, Deng-Chyang, Demuth, Dirk, Lindner, Dirk, Adsul, Shashi
Format: Artigo
Idioma:Inglês
Publicat: Korean Association for the Study of Intestinal Diseases 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873399/
https://ncbi.nlm.nih.gov/pubmed/32877600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2019.09159
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars